SPONSORS
EHMSG 2024 gratefully acknowledges the support of the following companies and institutions
RICHEN EUROPE is the European operating branch of the RICHEN GROUP, a major international group of medical device manufacturers with a global commitment. The company specializes in developing the best solutions for patients in the field of gastroenterology. Over the years our R&D department has excelled in the design and development of high-performance safe equipment and reagents for the diagnosis of Helicobacter pylori infection. Since 2015, the Richen Group has been supporting the European Helicobacter & Microbiota Study Group (EHMSG) as Platinum Sponsor.
INFAI is specialized in the transfer of advanced analytical technology in the field of medical diagnostics and the development of innovative pharmaceutical products. The company is a pioneer in the use of stable isotopes in gastroenterology, cardiovascular and inborn metabolic diseases. Helicobacter Test INFAI (HTI) is approved in centralized procedure by EMA first time in all European countries since 1997 and available for routine diagnosis of Helicobacter pylori infection. Until now more than 7.5 Mio HTI performed worldwide. In the meantime, HTI is registered as medicinal product (medical prescription) in more than 40 countries worldwide.
INFAI's laboratories in Bochum, Germany and in York, England are equipped with state-of-the-art IRMS mass spectrometer and 600 MHz NMR spectrometer which is used to investigate metabolic disorders, cardiovascular diseases and a number of other diseases. These facilities are used for internal research and product development, but are also available for collaborative and contract research. In last 10 years, a range of non-invasive, highly efficient breath tests using stable isotopes has been developed. REFEX (for patients taking PPI’s or patients with atrophic gastritis), Gastromotal (13C octanoic acid gastric emptying test) and Pancreo-Lip (13C mixed triglyceride exocrine pancreatic function test) are in preparation for approval by EMA but now available for clinical studies. INFAI is associated with a number of companies in several European countries and outside the Europe. All other developed products of INFAI you can find on our website: www.infai1.com.
Since 1997, INFAI GmbH has been supporting the European Helicobacter & Microbiota Study Group (EHMSG) as Gold Sponsor.
EHMSG POSTGRADUATE COURSE
Gold Sponsor
FUJIFILM Portugal is a subsidiary of FUJIFILM Europe based in Vila Nova de Gaia, responsible for the distribution of products and solutions for Imaging, Graphic Communication and Healthcare.
The Imaging area includes products, equipment, services and software for photographic printing, as well as instant photography, mirrorless digital cameras, lenses, accessories and lenses for the film industry.
The Graphic Communication area contains large format digital printing systems, software solutions for workflow management and POD.
The Healthcare area embraces a broad and comprehensive portfolio of medical solutions, which allow for a better and more efficient response in prevention, treatment and diagnosis. This involves CT, MRI, X-rays, Women's Health, Endoscopy, Ultrasound, IVD and ART. Regarding Medical Informatics, we have many platforms, such as PACS (Communication System and Image Archive), RIS, Artificial Intelligence and 3D reconstruction.
Silver Sponsor
Alfasigma is one of the top 5 pharmaceutical companies in Italy.
With an extensive presence in the international market, Alfasigma can count on a large number of direct branches in 17 countries, 2 Research & Development centers, 6 manufacturing plants, as well as on a network of top-level distributors which guarantee its products distribution on five continents and in more than 80 countries.
Alfasigma, leader in the gastrointestinal area, has a portfolio that ranges from prescription specialties to self-medication products, up to nutraceuticals.”
EHMSG WORKSHOP
Biocodex is a French pharmaceutical company founded in 1953 to develop and market the world’s first probiotic yeast strain, Saccharomyces boulardii CNCM I-745®. Today, Biocodex focuses its business on three main areas: Microbiota care; Women’s health; Orphan diseases. With more than 1,700 employees, Biocodex generated net revenues of above €560 million in 2023, including 35% in France and 65% internationally. The group is present in 115 countries through wholly owned subsidiaries in 16 countries and a network of distributors worldwide.
With its solid knowledge and vast experience, Daylife offers innovative, high-quality products and services to healthcare professionals. By investing in training and certification of its employees, it guarantees the best advice, implementation and monitoring of the solutions it puts on the market. Its values are manifested by a close, people-centered approach and an effective concern for environmental impact.
GenoScreen is a biotech company specialized in molecular microbiology. Alongside expert analytical services, our company develop molecular diagnostic tools to explore and exploit the properties of microbiotas, for research or innovation purposes for the benefit of the health, agri-food and environment. Our solutions are used in more than 80 countries worldwide in academia, industry, hospital, pharmaceutical institutions. Among them, “Deeplex HelP,” is a culture-free targeted-based deep sequencing assay, for identification, virulence and antibiotic resistance prediction of Helicobacter pylori.
Juvisé Pharmaceuticals is a pharmaceutical company whose mission is to prioritize essential medicines and improve the health of millions of people around the world.
Since our creation in 2008, our portfolio has been built up through the acquisition of princeps drugs from major pharmaceutical companies. Today, it includes 10 medications and covers 4 main therapeutic areas: neuroscience, gastroenterology, oncology and cardiology.
Juvisé Pharmaceuticals is an international company with a strong European focus. The majority of our medicines are manufactured in Europe (81% in 2023, with an ambitious target of close to 100% by the end of 2024), and marketed in nearly 80 countries worldwide.
Mayoly Diagnostics aims to become a world leader in diagnostics and eradication control of Helicobacter pylori infections. We are offering innovative and trusted in vitro diagnostic solutions based on 13C Urea Breath Tests (non-radioactive) and 14C Urea Breath Tests (low radioactivity) for clinicians, pharmacies, laboratories and patients.
We today have customers in more than 50 countries and now yearn for expanding in new international countries.
Come to visit us at booth n° 2!
GRANTS
EHMSG gratefully acknowledges a grant from the UEG
United European Gastroenterology (UEG) is Europe’s home and umbrella for multidisciplinary gastroenterology and unites over 50,000 engaged professionals from national and specialist societies, individual digestive health experts, and related scientists from all fields and career stages. As the leading non-profit organisation for excellence in digestive health, UEG improves the prevention and care of digestive diseases in Europe through providing top tier education, supporting research, and advancing clinical standards. The myUEG Community enables digestive health professionals from across the globe to become myUEG Associates and thereby connect, network and benefit from a wide range of free resources and educational activities.
UEG Week 2024 – October 12-15
in Vienna and online
The multidisciplinary UEG Week and Postgraduate Teaching (PGT) are the premier venues for researchers from across the globe to present their latest findings.
Abstract submission is open February 26 – April 26, 2024, Midnight (CET). More information: https://ueg.eu/week/programme/abstracts
Scientific programme: Top-tier multidisciplinary science awaits! In every session, delegates have the opportunity to interact in real-time via our Q&A tool both in-person and virtually. Access the online programme here: https://ueg.eu/week/programme
Attractive registration packages to participate onsite in Vienna or online: https://ueg.eu/week/attendance
Join the multidisciplinary and multinational myUEG community in Vienna or online!
myUEG Community – Become a myUEG Associate and strengthen your digestive health network!
Our myUEG Community is your connection to an international and multidisciplinary digestive health community all-year-round. A plethora of outstanding free resources and educational activities await you. Become a myUEG Associate or myUEG Young GI Associate for free today! Grow a diverse digestive health network of friends, colleagues, peers and collaborators within the community via our exclusive, safe and secure My Connect networking platform.
Join us for free today: www.ueg.eu/myueg-community
This is your myUEG Community daily – resources and opportunities every day of the year
UEG has something to offer you every day. Besides UEG Week and Postgraduate Teaching, take a look at the multitude of live resources, such as our dynamic, free online courses and webinars, many of which you can join live, and the Career Development. Furthermore, you can check out face-to-face events such as our renowned Summer School and our Masterclass.
Can’t join live? Not a problem. With Mistakes in... articles, GI Guidelines App, Journal Podcasts, on-demand recordings and the world’s largest GI Networking platform My Connect, there are opportunities for our myUEG Community to learn daily.
Find the full line-up and all details here: https://ueg.eu/education